Aspen Aerogels price target lowered to $16 from $22 at Roth MKM

Roth MKM analyst Chip Moore lowered the firm’s price target on Aspen Aerogels (ASPN) to $16 from $22 but keeps a Buy rating on the shares after its Q4 results and below-consensus Q1 guide. Regulatory/macro uncertainty limits near-term visibility, but there is little current downside potential and the stock represents an attractive longer-term opportunity, the analyst tells investors in a research note. Proactive cost actions also look to support underlying profitability, Roth adds.